Tanke Biosciences Corp Cash Flow Statement
TNBI|3 years of annual SEC 10-K data (FY2010-FY2012)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Tanke Biosciences Corp used $1M in operating cash flow and negative free cash flow of $2M in FY2012.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2012 | FY2011 | FY2010 |
|---|---|---|---|
| Net Income | -$210.2K | -$3.1M | $2.7M |
| Depreciation & Amortization | $636.3K | $400.0K | $136.1K |
| Operating Cash Flow | -$1.2M | $3.7M | $4.4M |
| Capital Expenditures | $856.4K | $701.0K | $76.1K |
| Free Cash Flow | -$2.0M | $3.0M | $4.3M |
| FCF Margin | -7.1% | 12.4% | 21.4% |